Clinical Trial Update: A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Hope Biosciences' autologous mesenchymal stem cell therapy (HB-adMSCs) trial for Alzheimer disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: WITHDRAWN